These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 2957053

  • 1. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
    Locker GY, Kilton L, Hoeltgen T, Knop RH, Benson AB, Chernicoff D, Barrett J, Blough R, Johnson C.
    Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053
    [No Abstract] [Full Text] [Related]

  • 2. Phase II trial of 4-demethoxydaunorubicin in advanced colorectal carcinoma.
    Harper HD, Kemeny NE, Ahmed T, Cheng E, Arena F, Sordillo P, Faye L.
    Cancer Treat Rep; 1984 Apr; 68(4):689-90. PubMed ID: 6585273
    [No Abstract] [Full Text] [Related]

  • 3. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM, Mitchell EP, Woolley PV, Smith FP, Neefe J, Smith L, Schein PS.
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract] [Full Text] [Related]

  • 4. Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial.
    Locker GY, Lanzotti V, Sweet D, Lad T, Khandekar J, Stiff P, Johnson C, Miller S.
    Cancer Treat Rep; 1984 Oct; 68(10):1303-4. PubMed ID: 6525605
    [No Abstract] [Full Text] [Related]

  • 5. Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.
    Sigman LM, Van Echo DA, Egorin MJ, Whitacre MY, Aisner J.
    Cancer Treat Rep; 1986 Jun; 70(6):721-5. PubMed ID: 2942244
    [Abstract] [Full Text] [Related]

  • 6. Phase II study of i.v. menogaril in patients with malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group Study.
    McCulloch PB, Eisenhauer EA, Shibata HR, Young VP.
    Cancer Treat Rep; 1987 Jun; 71(7-8):771-2. PubMed ID: 2955887
    [No Abstract] [Full Text] [Related]

  • 7. Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung.
    Joss RA, Monfardini S, Hansen M, Dombernowsky P, Renard J, Pinedo HM.
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):263-5. PubMed ID: 2833403
    [No Abstract] [Full Text] [Related]

  • 8. Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial.
    Gundersen S, Monfardini S, Renard G, Van Glabbeke M, Pinedo H.
    Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1707-8. PubMed ID: 2962875
    [No Abstract] [Full Text] [Related]

  • 9. Phase II study of N-methylformamide in patients with advanced colorectal cancer.
    Tchekmedyian NS, Kaplan RS, Eisenberger M, Abrams J, Van Echo D.
    Cancer Treat Rep; 1987 May; 71(5):541-2. PubMed ID: 3567980
    [No Abstract] [Full Text] [Related]

  • 10. Phase II trial of menogaril in advanced colorectal cancer.
    Holdener EE, ten Bokkel Huinink WW, Decoster G, Ludwig C, Renard G, Pinedo HM.
    Invest New Drugs; 1988 Sep; 6(3):227-30. PubMed ID: 2973448
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group.
    Sessa C, Kaye SB, Renard J, ten Bokkel Huinink W, Cavalli F.
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):751-2. PubMed ID: 2523809
    [No Abstract] [Full Text] [Related]

  • 12. Phase I and pharmacokinetic study of menogaril administered as a 72-hour continuous i.v. infusion.
    Long HJ, Powis G, Schutt AJ, Moertel CG.
    Cancer Treat Rep; 1987 Jun; 71(6):593-8. PubMed ID: 2953414
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
    Cowan JD, Von Hoff DD, McDonald B, Talley RW, McCracken JD, Chen T.
    Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial.
    Locker GY, Hoeltgen T, Kilton L, Krauss S, McNamara M, Blough R, Johnson C.
    Cancer Treat Rep; 1987 Sep; 71(7-8):765-6. PubMed ID: 3300969
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phase II trial of bisantrene in advanced colorectal cancer: a cancer and leukemia group B study.
    Perry MC, Forastiere AA, Richards F, Weiss RB, Anbar D.
    Cancer Treat Rep; 1982 Nov; 66(11):1997-8. PubMed ID: 7139643
    [No Abstract] [Full Text] [Related]

  • 19. Phase II study of chlorozotocin in the treatment of advanced colorectal cancer.
    Lawton JO, Giles GR, Hall J, MacAdam A, Hall R, Matheson T, Bird G.
    Cancer Treat Rep; 1981 Nov; 65(1-2):13-15. PubMed ID: 6452945
    [Abstract] [Full Text] [Related]

  • 20. Phase II trial of maytansine in patients with advanced colorectal carcinoma.
    O'Connell MJ, Shani A, Rubin J, Moertel CG.
    Cancer Treat Rep; 1978 Aug; 62(8):1237-8. PubMed ID: 356981
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.